These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16514388)

  • 1. [Palliative chemotherapy for pancreatic cancer].
    Buscail L; Bournet B; Guimbaud R
    Gastroenterol Clin Biol; 2006 Jan; 30(1):106-9. PubMed ID: 16514388
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy and other supportive modalities in the palliative setting for pancreatic cancer.
    Sullivan KM; Kozuch PS
    Cancer J; 2012; 18(6):633-41. PubMed ID: 23187852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Has there been progress in the treatment of metastatic pancreatic cancer?].
    Jerusalem G; Bours V; Fillet G
    Rev Med Liege; 2000 Mar; 55(3):146-8. PubMed ID: 10823002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Locoregional and systemic therapy of advanced pancreatic carcinoma].
    Gebauer T; Ridwelski K; Fahlke J; Lippert H
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1344-7. PubMed ID: 9931877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced pancreatic cancer - how to choose an adequate treatment option.
    Korkeila EA
    World J Gastroenterol; 2015 Oct; 21(38):10709-13. PubMed ID: 26478662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should further studies of chemotherapy be carried out in pancreatic cancer?
    Taylor I
    Eur J Cancer; 1993; 29A(8):1076-8. PubMed ID: 7686019
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic Approaches for Metastatic Pancreatic Adenocarcinoma.
    Rubinson DA; Wolpin BM
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):761-76. PubMed ID: 26226909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is there an advantage to neo- or adjuvant chemotherapy in pancreatic cancer?].
    Klapdor R
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():135-47. PubMed ID: 1724194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronopharmacologic approach to the administration of anticancer agents in pancreatic adenocarcinoma. Pilot experience].
    Focan C; Kreutz F; Focan-Henrard D; Moeneclaey N; Gillard V; Delforge M; Dallemagne B; Weerts J; Closon MT; Honoré P
    Rev Med Liege; 2000 Mar; 55(3):149-53. PubMed ID: 10823003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer.
    Pacheco-Barcia V; Mondéjar Solís R; France T; Asselah J; Donnay O; Zogopoulos G; Bouganim N; Guo K; Rogado J; Martin E; Alcindor T; Colomer R
    Pancreas; 2019; 48(5):e45-e47. PubMed ID: 31090669
    [No Abstract]   [Full Text] [Related]  

  • 11. Palliative treatment of pancreatic cancer.
    von Wichert G; Seufferlein T; Adler G
    J Dig Dis; 2008 Feb; 9(1):1-7. PubMed ID: 18251787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonging survival in inoperable pancreatic cancer with combination chemotherapy.
    Goel AK; Seenu V
    Trop Gastroenterol; 1995; 16(2):141-3. PubMed ID: 8644365
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequential polychemotherapy in exocrine pancreatic cancer.
    Klapdor R; Bahlo M; Babinski A; Broemel T; Müller C; Seutter R
    Anticancer Res; 2003; 23(2A):841-4. PubMed ID: 12820310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives in chemotherapy of pancreatic cancer.
    Klapdor R
    Eur J Surg Oncol; 1991 Apr; 17(2):153-66. PubMed ID: 1707835
    [No Abstract]   [Full Text] [Related]  

  • 15. Palliative care from the beginning of treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Lazenby JM; Saif MW
    JOP; 2010 Mar; 11(2):154-7. PubMed ID: 20208326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative outcomes between initially unresectable and recurrent cases of advanced pancreatic cancer following palliative chemotherapy.
    Xue P; Kanai M; Mori Y; Nishimura T; Uza N; Kodama Y; Kawaguchi Y; Takaori K; Matsumoto S; Uemoto S; Chiba T
    Pancreas; 2014 Apr; 43(3):411-6. PubMed ID: 24622071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic pancreatic cancer: the dilemma of quality vs. quantity of life.
    Shahrokni A; Saif MW
    JOP; 2013 Jul; 14(4):391-4. PubMed ID: 23846935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pancreatic carcinoma. Is there a role for radiotherapy and chemotherapy?
    Wils JA; Bleiberg H
    Acta Gastroenterol Belg; 1987; 50(1):114-20. PubMed ID: 2447729
    [No Abstract]   [Full Text] [Related]  

  • 19. Small-cell neuroendocrine carcinoma of the uterine cervix with pancreatic metastasis: a case report and a review of the literature.
    Lee EJ; Hwang J; Kim DW
    J Obstet Gynaecol; 2019 May; 39(4):573-575. PubMed ID: 30744460
    [No Abstract]   [Full Text] [Related]  

  • 20. Metastatic pancreatic cancer: emerging strategies in chemotherapy and palliative care.
    el-Kamar FG; Grossbard ML; Kozuch PS
    Oncologist; 2003; 8(1):18-34. PubMed ID: 12604729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.